Ex vivo generation of highly purified and
activated natural killer cells from human peripheral blood.
Saito S, Harada Y, Morodomi Y, Onimaru M, Yoshida K, Kyuragi R,
Matsubara H, Yonemitsu Y.
Hum Gene Ther Methods. 2013 Aug;24(4):241-52. doi:
10.1089/hgtb.2012.183.
DVC1-0101 to treat peripheral arterial disease: a Phase I/IIa
open-label dose-escalation clinical trial.
Yonemitsu Y, Matsumoto T, Itoh H, Okazaki J, Uchiyama M, Yoshida K,
Onimaru M, Onohara T, Inoguchi H, Kyuragi R, Shimokawa M, Ban H, Tanaka
M, Inoue M, Shu T, Hasegawa M, Nakanishi Y, Maehara Y.
Mol Ther. 2013 Mar;21(3):707-14. doi: 10.1038/mt.2012.279. Epub 2013
Jan 15.
Dedifferentiated liposarcoma of the spermatic cord with a
hemangioendothelioma-like component: a case report and review of the
literature.
Okano S, Yamamoto H, Kono S, Fujii H, Shirabe K, Maehara Y, Oda Y.
Pathol Res Pract. 2013 Sep;209(9):596-604
Nakano T, Ninomiya T, Sumiyoshi S, Onimaru M, Fujii H, Itabe H, Nakashima Y, Sueishi K, Tsuruya K, Oda Y, Kitazono T, Kiyohara Y.
Kidney Int. 2013 Aug;84(2):373-80.
Fas-deficient fully allogeneic dendritic cells administered via an intratumoral injection route show efficient antitumor effects in murine models.
Okano S, Kondoh H, Toshima T, Nakagawara H, Yoshizumi T, Soejima Y, Shirabe K, Harada M, Yoshikai Y, Maehara Y.
Fukuoka Igaku Zasshi. 2013 Jan;104(1):15-26.
CD4 T cell-mediated masking effects of the immunogenicity of tumor-associated antigens are qualitatively and quantitatively different depending on the individual antigens.
Okano S, Matsumoto Y, Yoshiya S, Yamashita Y, Harimoto N, Ikegami T, Shirabe K, Harada M, Yoshikai Y, Maehara Y.
Fukuoka Igaku Zasshi. 2013 Jan;104(1):1-14.
橋本修一, 中川 和憲,「研究手法入門：生化学・免疫学実験法」 免疫組織化学的染色法,呼吸,2013.12.
中島豊, 中川 和憲、大動脈瘤・大動脈解離 改訂第2版、最新医学社、2013年10月 pp35-41
